The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levels
Abstract
OBJECTIVE: Long-term treatment with nondepolarizing neuromuscular blocking agents and corticosteroids in the intensive care unit is not benign, and an increasing number of patients with acute quadriplegic myopathy have been reported with increased use of these drugs. The purpose of this study was to investigate the mechanisms underlying acute quadriplegic myopathy. DESIGN: Percutaneous muscle biopsy samples were obtained, and electrophysiologic examinations were performed during the acute phase and during recovery in patients with acute quadriplegic myopathy. Regulation of muscle contraction and myofibrillar protein synthesis was studied using cell physiologic techniques, ultrasensitive electrophoresis, in situ hybridization, and histopathologic techniques. SETTING: All patients were seen in the intensive care unit of different university hospitals. PATIENTS: All patients were critically ill with sepsis. They had been given massive doses of corticosteroids in combination with variable doses of neuromuscular blocking agents. All patients developed paralysis of spinal nerve-innervated muscles. On the other hand, cranial nerve-innervated muscle and sensory and cognitive functions were well maintained after discontinuation of treatment with neuromuscular blocking agents. INTERVENTION: Muscle biopsy samples were obtained and electrophysiologic examinations were performed in all patients. MEASUREMENTS AND MAIN RESULTS: The major observations in patients with acute quadriplegic myopathy were, as follows: a) a general decrease in myofibrillar protein content; b) specific but highly variable partial or complete loss of myosin and myosin-associated proteins; c) very low thick-filament/thin-filament protein ratios; d) absence of myosin messenger RNA; and e) a dramatically impaired muscle cell force-generating capacity in the acute phase of acute quadriplegic myopathy. During clinical improvement, normal expression of myosin messenger RNAs, reexpression of thick-filament proteins, and increased specific tension were observed. CONCLUSIONS: Acute quadriplegic myopathy is associated with a specific decrease in thick-filament proteins related to an altered transcription rate. Although the decreased content of thick-filament proteins is important for prolonged muscle weakness, it is not the primary cause of muscle paralysis in the acute stage, during which impaired muscle membrane excitability probably plays a more significant role. Several factors contribute to this condition, but the action of corticosteroids seems to be the predominant one, along with potentiation by neuromuscular blocking agents, immobilization, and probably also concurrent sepsis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gunning, P., Ponte, P., Okayama, H., Engel, J., Blau, H., & Kedes, L. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.5.787-795.1983 · Cited by 1,196
Three myosin heavy chain isoforms in type 2 skeletal muscle fibres
Schiaffino, S., Gorza, L., Sartore, S., Saggin, L., Ausoni, S., Vianello, M., Gundersen, K., & LØmo, T. (1989) · Journal of Muscle Research and Cell Motility · doi:10.1007/bf01739810 · Cited by 954
Self-citationGunning, P., Ponte, P., Okayama, H., Engel, J., Blau, H., & Kedes, L. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.5.787 · Cited by 547
Larsson, L., & Moss, R. L. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019964 · Cited by 513
Self-citationType IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle
Smerdu, V., Karsch-Mizrachi, I., Campione, M., Leinwand, L., & Schiaffino, S. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.267.6.c1723 · Cited by 456
Self-citationGiulian, G. G., Moss, R. L., & Greaser, M. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90551-1 · Cited by 399
Larsson, L., Li, X., & Frontera, W. R. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.272.2.c638 · Cited by 367
Self-citationMedina, R., Wing, S. S., & Goldberg, A. L. (1995) · Biochemical Journal · doi:10.1042/bj3070631 · Cited by 293
Moss, R. L. (1979) · The Journal of Physiology · doi:10.1113/jphysiol.1979.sp012845 · Cited by 271
Muscle weakness in mechanically ventilated patients with severe asthma.
Leatherman, J. W., Fluegel, W. L., David, W. S., Davies, S. F., & Iber, C. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.5.8630621 · Cited by 257
Cited by
Sarcopenia: Aging-Related Loss of Muscle Mass and Function
Larsson, L., Degens, H., Li, M., Salviati, L., Lee, Y. I., Thompson, W., Kirkland, J. L., & Sandri, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00061.2017 · Cited by 1,797
Self-citationGlucocorticoid receptor signaling in health and disease
Kadmiel, M., & Cidlowski, J. A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.07.003 · Cited by 849
Side Effects of Corticosteroid Therapy
Buchman, A. L. (2001) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200110000-00006 · Cited by 745
Disorders of the Respiratory Muscles
Laghi, F., & Tobin, M. J. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2206020 · Cited by 687
Fan, E., Cheek, F., Chlan, L., Gosselink, R., Hart, N., Herridge, M. S., Hopkins, R. O., Hough, C. L., Kress, J. P., Latronico, N., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201411-2011st · Cited by 553
Metadata
- Authors
- Larsson, L., Li, X., Edström, L., Eriksson, L. I., Zackrisson, H., Argentini, C., & Schiaffino, S.
- Venue
- Critical Care Medicine
- Published
- 2000-01
- Volume
- 28
- Issue
- 1
- Pages
- 34-45
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2071165824
- Cited by
- 255
- References
- 28
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levels. https://app.cochat.ai/papers/10.1097/00003246-200001000-00006
- The paper
- Larsson, L., Li, X., Edström, L., Eriksson, L. I., Zackrisson, H., Argentini, C., & Schiaffino, S. (2000). Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levels. Critical Care Medicine. https://doi.org/10.1097/00003246-200001000-00006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.